Dientamoeba fragilis colonization is not associated with gastrointestinal symptoms in children at primary care level

Family Practice

Volumn 34, Issue 1, 2017, Pages 25-29

  Holtman, Gea A ^a   Kranenberg, Justin J ^a   Blanker, Marco H ^a   Ott, Alewijn ^b   Lisman van Leeuwen, Yvonne ^a   Berger, Marjolein Y ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Certe Afd Medische Microbiologie   (Netherlands)

Author keywords

Dientamoeba fragilis; Gastrointestinal symptoms; Paediatrics; Primary care

Indexed keywords

ABDOMINAL PAIN; AROUSAL; ARTICLE; ASYMPTOMATIC DISEASE; CASE CONTROL STUDY; CHILD; CHRONIC DIARRHEA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIENTAMOEBA; FATIGUE; FEMALE; FEVER; FUNCTIONAL ABDOMINAL PAIN; FUNCTIONAL CONSTIPATION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LOGISTIC REGRESSION ANALYSIS; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MICROBIAL COLONIZATION; PRIMARY MEDICAL CARE; RECTUM HEMORRHAGE; DIARRHEA; DIENTAMOEBIASIS; NORWAY; PRIMARY HEALTH CARE; SYMPTOM ASSESSMENT;

ABDOMINAL PAIN; ASYMPTOMATIC DISEASES; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DIARRHEA; DIENTAMOEBIASIS; FATIGUE; FEMALE; HUMANS; MALE; NORWAY; PRIMARY HEALTH CARE; SYMPTOM ASSESSMENT;

EID: 85014951360     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmw111     Document Type: Article

References (21)

1. Gieteling MJ, Lisman-van Leeuwen Y, van der Wouden JC, Schellevis FG, Berger MY. Childhood nonspecific abdominal pain in family practice: incidence, associated factors, and management. Ann Fam Med 2011; 9: 337-43.
2. Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D. A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2011; 2: 3-12.
3. de Wit MA, Koopmans MP, Kortbeek LM et al. Gastroenteritis in sentinel general practices, The Netherlands. Emerg Infect Dis 2001; 7: 82-91.
4. Röser D, Simonsen J, Nielsen HV, Stensvold CR, Mølbak K. Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur J Clin Microbiol Infect Dis 2013; 32: 1303-10.
5. Jepps MW, Dobell C. Dientamoeba fragilis n.g., n. sp.: a new intestinal amoeba from man. Parasitology 1918; 10: 352-67.
6. Johnson EH, Windsor JJ, Clark CG. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 2004; 17: 553-70, table of contents.
7. de Jong MJ, Korterink JJ, Benninga MA et al. Dientamoeba fragilis and chronic abdominal pain in children: a case-control study. Arch Dis Child 2014; 99: 1109-13.
8. Holtman GA, Lisman-van Leeuwen Y, Kollen BJ et al. Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin example. BMC Fam Pract 2013; 14: 179.
9. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-4.
10. Gijsbers CF, Benninga M, Büller H. Clinical and laboratory findings in 220 children with recurrent abdominal pain. Acta Paediatr 2011; 100: 1028-32.
11. Baber KF, Anderson J, Puzanovova M, Walker LS. Rome II versus Rome III classification of functional gastrointestinal disorders in pediatric chronic abdominal pain. J Pediatr Gastroenterol Nutr 2008; 47: 299-302.
12. Verweij JJ, Mulder B, Poell B et al. Real-time PCR for the detection of Dientamoeba fragilis in fecal samples. Mol Cell Probes 2007; 21: 400-4.
13. Stark D, Barratt J, Roberts T et al. Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples. Eur J Clin Microbiol Infect Dis 2010; 29: 411-6.
14. Engsbro AL, Stensvold CR, Vedel Nielsen H, Bytzer P. Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome. Scand J Infect Dis 2014; 46: 204-9.
15. Ohman L, Simren M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 2013; 15: 323.
16. Enserink R, Scholts R, Bruijning-Verhagen P et al. High detection rates of enteropathogens in asymptomatic children attending day care. PLoS One 2014; 9: e89496.
17. van Coppenraet LB, Dullaert-de Boer M, Ruijs G et al. Case-control comparison of bacterial and protozoan microorganisms associated with gastroenteritis: application of molecular detection. Clin Microbiol Infect 2015; 21: 592.e9-19.
18. Krogsgaard LR, Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study. Clin Gastroenterol Hepatol 2015; 13: 507-13.e2.
19. Johnson JA, Clark CG. Cryptic genetic diversity in Dientamoeba fragilis. J Clin Microbiol 2000; 38: 4653-4.
20. Stark D, Garcia LS, Barratt JL et al. Description of Dientamoeba fragilis cyst and precystic forms from human samples. J Clin Microbiol 2014; 52: 2680-3.
21. Röser D, Simonsen J, Stensvold CR et al. Metronidazole therapy for treating dientamoebiasis in children is not associated with better clinical outcomes: a randomized, double-blinded and placebo-controlled clinical trial. Clin Infect Dis 2014; 58: 1692-9.